Tryptamine Therapeutics completes phase 1b of IV-infused psilocin trial

By Proactive Investors / August 26, 2024 / www.youtube.com / Article Link


Tryptamine Therapeutics Ltd (ASX:TYP, OTC:TYPTF) CEO Jason Carroll joins Proactive's Tylah Tully to discuss the completion of ...

Recent News

Energy outperforms gold and tech for first time in years
March 23, 2026 / www.canadianminingreport.com

Gold stocks crash along with metal price
March 23, 2026 / www.canadianminingreport.com

Mining stock ETFs slide, gold sector valuations high
March 16, 2026 / www.canadianminingreport.com

Rise in oil price a potential net gain for Canada
March 16, 2026 / www.canadianminingreport.com

Gold stocks slump partly on fears of cost increases
March 09, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok